Science

Preclinical Pipeline

We discover and develop biologic and small molecule therapies for immune and fibrotic diseases as well as immuno-oncology therapies.

DiscoveryPreclinical
Development
Clinical
Development
DiscoveryPreclinical
Development
Clinical
Development
Immuno-oncology
KD033 (anti-PD-L1/IL-15 fusion protein)
KD033 (anti-PD-L1/IL-15 fusion protein)
IL-15 fusion protein with undisclosed antibody
IL-15 fusion protein with undisclosed antibody
Fibrosis
KD045
(pan-ROCK inhibitor)
KD045
(pan-ROCK inhibitor)
Immune Diseases
Undisclosed mAb
Undisclosed mAb